Arbutus Medical

Arbutus Medical focuses on developing advanced orthopedic power tools and sterile surgical kits to optimize trauma care and surgical efficiency in clinical settings. Founded in 2014 in Vancouver, Canada, Arbutus Medical specializes in orthopedic surgical tools and kits. In February 2026, Arbutus Medical raised CAD 9. 3 million in growth capital funding led by Credit Mutuel Equity, with participation from CU Healthcare Innovation Fund, Nimbus Synergies, ThresholdImpact, Genome British Columbia, MEDTEQ+.

The founder has a background in the medical device industry, though specific details on prior companies are not available. Arbutus Medical specializes in the development and provision of advanced orthopedic power tools and sterile surgical kits designed to optimize trauma care and enhance surgical efficiency. The company's flagship products include the TrakPak®, Digit Revision SwiftKit™, HEX Drill Kit, and PRO Drill Kit, each engineered to address specific surgical needs. These tools facilitate various orthopedic procedures, such as skeletal traction and fingertip revision amputation, leveraging technologies that convert commercial drills into licensed surgical devices for use in clinical settings.

Arbutus Medical serves a diverse clientele, including trauma centers, emergency rooms, hospital operating rooms, NGOs, veterinarians, and military field medicine units across North America and potentially other international markets. The solutions provided by Arbutus Medical are designed to streamline processes and improve patient outcomes, reinforcing their commitment to innovation in orthopedic surgical care. Arbutus Medical generates revenue through direct sales of its surgical tools and procedure kits to hospitals, healthcare providers, and medical institutions. The company employs a B2B transaction structure, working closely with distributors and healthcare professionals to deliver their products.

Transactions are structured to facilitate bulk orders, with potential partnerships established to support ongoing product supply and training services. The pricing model for products like the TrakPak® and Digit Revision SwiftKit™ is aligned with industry standards, reflecting their value in improving surgical efficiency and patient care. The company’s overall revenue is driven by the adoption of their flagship products and ongoing relationships with healthcare providers, ensuring a consistent demand for their innovative solutions in orthopedic surgery. The company plans to utilize the February 2026 funding to grow its commercial team in the US, support clinical education initiatives, increase manufacturing capabilities, introduce new products, and broaden its portfolio of intellectual property.